It can reduce the weight index and hydroxyproline content, delay the process of pulmonary fibrosis and inhibit TGF-β1 mRNA expression in the bleomycin-induced pulmonary fibrosis model [66, 67]. The gene discussed is TGFB1; the disease is pulmonary fibrosis.